SCHEMBL337752

SCHEMBL337752

CCCCCCCCCCC(C)(C(=O)[O-])S(=O)(=O)O.[Na+]

nearest known ligand 0.42

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CA2 known ✓ P00918 1/20 0.42
CA1 known ✓ P00915 1/20 0.36
FDPS known ✓ P14324 4/20 0.35
CES2 O00748 4/20 0.38
CES1 P23141 3/20 0.38
GGPS1 O95749 3/20 0.36
GLA P06280 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
EPHX2 P34913 1/20 0.35
RECQL P46063 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1484417 1.00 CA2 (0.42) CA2CES2CES1CA1GGPS1
SCHEMBL7178944 1.00 CA2 (0.42) CA2CES2CES1CA1GGPS1
Lithium Ion SCHEMBL1484424 0.96 CES2 (0.38) CA2CES2CES1GGPS1FDPS
Potassium Ion SCHEMBL1484421 0.96 CES2 (0.38) CA2CES2CES1GGPS1FDPS
SCHEMBL7199650 0.86 CA2 (0.42) CA2CES2CES1CA1GGPS1
SCHEMBL11660121 0.81 CES2 (0.40) CES2GGPS1TSHR
SCHEMBL27508982 0.81 CES2 (0.40) CES2GGPS1TSHR
SCHEMBL3052895 0.81 CES2 (0.40) CES2GGPS1TSHR
SCHEMBL5342660 0.81 CES2 (0.40) CES2GGPS1TSHR
SCHEMBL27615120 0.81 CES2 (0.40) CES2GGPS1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4594456-A1 HARD SURFACE CLEANING COMPOSITIONS COMPRISING RHAMNOLIPIDS AND SULFONATED ALKYL ESTERS CO-SURFACTANT Stepan Company (US) 2025-08-06 EP claimed
US-20250223516-A1 HARD SURFACE CLEANING COMPOSITIONS COMPRISING RHAMNOLIPIDS AND SULFONATED ALKYL ESTERS COSURFACTANT STEPAN CO (US) 2025-07-10 US claimed
CN-118078667-A Compositions comprising zwitterionic alkyl-alkanoylamides and/or alkyl alkanoates 强生消费者公司 2024-05-28 CN claimed
WO-2024073331-A1 HARD SURFACE CLEANING COMPOSITIONS COMPRISING RHAMNOLIPIDS AND SULFONATED ALKYL ESTERS CO-SURFACTANT STEPAN COMPANY (US) 2024-04-04 WO claimed
WO-2023154183-A1 COMPOSITION INCLUDING EFFERVESCENT AGENTS, BIOSTIMULANT, NUTRIENT, AND PESTICIDE ROBBINS JEFFREY (US) 2023-08-17 WO claimed
US-20230172194-A1 COMPOSITION INCLUDING EFFERVESCENT AGENTS, BIOSTIMULANT, NUTRIENT, AND PESTICIDE ROBBINS JEFFREY HANSON (US) 2023-06-08 US claimed
CN-115778889-A Personal care compositions 高露洁-棕榄公司 2023-03-14 CN claimed
US-12629327-B2 Keratin-based hair straightening formulations, methods and systems BEAUTY BIOLABS LLC (US) 2026-05-19 US disclosed
US-12605321-B2 Personal care compositions COLGATE-PALMOLIVE COMPANY (US) 2026-04-21 US disclosed
US-20260071150-A1 MICROBIAL ENHANCED COMPOSITIONS WHICH OVERCOME ANTAGONISTIC SURFACTANT INCOMPATIBILITY STEPAN CO (US) 2026-03-12 US disclosed
US-20250250506-A1 HARD SURFACE CLEANING COMPOSITIONS COMPRISING RHAMNOLIPIDS AND ALKYL SULFATE CO-SURFACTANT STEPAN CO (US) 2025-08-07 US disclosed
EP-4594456-A1 HARD SURFACE CLEANING COMPOSITIONS COMPRISING RHAMNOLIPIDS AND SULFONATED ALKYL ESTERS CO-SURFACTANT Stepan Company (US) 2025-08-06 EP disclosed
US-20250223516-A1 HARD SURFACE CLEANING COMPOSITIONS COMPRISING RHAMNOLIPIDS AND SULFONATED ALKYL ESTERS COSURFACTANT STEPAN CO (US) 2025-07-10 US disclosed
US-6861397-B2 Compositions having enhanced deposition of a topically active compound on a surface THE DIAL CORPORATION (US) 2005-03-01 US disclosed
WO-2004004677-A1 COMPOSITIONS HAVING ENHANCED DEPOSITION OF A TOPICALLY ACTIVE ON A SURFACE THE DIAL CORPORATION (US) 2004-01-15 WO disclosed
US-20030125224-A1 Compositions having enhanced deposition of a topically active compound on a surface HENKEL AG & CO. KGAA (DE) 2003-07-03 US disclosed
US-6451748-B1 ANTIBACTERIAL COMPOSITION COMPRISING: A PHENOLIC ANTIMICROBIAL AGENT; A SURFACTANT SELECTED FROM THE GROUP CONSISTING OF AN ANIONIC SURFACTANT, A CATIONIC SURFACTANT, A NONIONIC SURFACTANT, AND MIXTURES THEREOF; WITH SULFONATES THE DIAL CORPORATION 2002-09-17 US disclosed
EP-1191843-A2 ANTIBACTERIAL COMPOSITIONS The Dial Corporation (US) 2002-04-03 EP disclosed
WO-2000078275-A2 ANTIBACTERIAL COMPOSITIONS THE DIAL CORPORATION (US) 2000-12-28 WO disclosed
US-6107261-A PHENOLIC ANTIBACTERIAL AGENT, A SURFACTANT, HYDROTROPE, WATER SOLUBLE HYDRIC SOLVENT, AND WATER, WHEREIN A PERCENT SATURATION OF THE ANTIBACTERIAL AGENT IN A CONTINUOUS AQUEOUS PHASE OF THE COMPOSITION IS AT LEAST 50% THE DIAL CORPORATION (US) 2000-08-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12629327-B2 Keratin-based hair straightening formulations, methods and systems KRT18, HCN4, COL14A1 CA2 154/4885CA1 455/4885FDPS 4362/4885
US-20030125224-A1 Compositions having enhanced deposition of a topically active compound on a surface LIPA, CUTA, DHCR7 CA2 427/4885CA1 736/4885FDPS 1456/4885
US-20260071150-A1 MICROBIAL ENHANCED COMPOSITIONS WHICH OVERCOME ANTAGONISTIC SURFACTANT INCOMPATIBILITY SGMS2, SGMS1, PHOSPHO1 CA2 128/4885CA1 527/4885FDPS 4323/4885
US-12605321-B2 Personal care compositions SMURF1, S100A10, SMURF2 CA2 1029/4885CA1 2014/4885FDPS 3681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.